mCRC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
mCRC
May 16, 2024, 16:51 |
Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 15, 2024, 13:47 |
Societies
Interview with Eric Van Cutsem and Zorana Maravic on the ESMO Daily Reporter - ESMO
The European Society for Medical Oncology (ESMO) shared on X: “While novel agents continue to…
Apr 18, 2024, 09:40 |
Insight
Chiara Cremolini: New real world data about BRAF mutant mCRC. What are we doing after the targeted therapy?
Chiara Cremolini, Associate Professor in Medical Oncology at the University of Pisa, shared a post…
Mar 16, 2024, 20:07 |
Insight
Erman Akkus: HER2 and mCRC on Journal of Clinical Oncology
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "HER2 and mCRC on…
Mar 11, 2024, 03:11 |
Blog
Herbert Loong: A privilege to participate and co-chair an informative event held at Amgen Oncology in Kuala Lumpur
Herbert Loong, Clinical Associate Professor at the Chinese University of Hong Kong, shared on X/Twitter:…
All:
5
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube